Exact Mass: 408.095095

Exact Mass Matches: 408.095095

Found 30 metabolites which its exact mass value is equals to given mass value 408.095095, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Xylerythrin

Xylerythrin

C26H16O5 (408.0997686)


   

methyl eriodermate

methyl eriodermate

C20H21ClO7 (408.09757460000003)


   

3-chloro-9beta,15-dihydroxy-8beta-tiglinoyloxy-dehydrleucodin

3-chloro-9beta,15-dihydroxy-8beta-tiglinoyloxy-dehydrleucodin

C20H21ClO7 (408.09757460000003)


   

Cys Asp Asp Gly

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-3-{[(1S)-2-carboxy-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)


   

Cys Asp Gly Asp

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]acetamido}butanedioic acid

C13H20N4O9S (408.095095)


   

Cys Gly Asp Asp

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carboxypropanamido]butanedioic acid

C13H20N4O9S (408.095095)


   

Asp Cys Asp Gly

(3S)-3-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C13H20N4O9S (408.095095)


   

Asp Cys Gly Asp

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]acetamido}butanedioic acid

C13H20N4O9S (408.095095)


   

Asp Asp Cys Gly

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)


   

Asp Asp Gly Cys

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C13H20N4O9S (408.095095)


   

Asp Gly Cys Asp

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-sulfanylpropanamido]butanedioic acid

C13H20N4O9S (408.095095)


   

Asp Gly Asp Cys

(3S)-3-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)


   

Gly Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C13H20N4O9S (408.095095)


   

Gly Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C13H20N4O9S (408.095095)


   

Gly Asp Asp Cys

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C13H20N4O9S (408.095095)


   

4-[4,5-DIHYDRO-5-(1H-INDOL-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-BENZENESULFONAMIDE

4-[4,5-DIHYDRO-5-(1H-INDOL-3-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]-BENZENESULFONAMIDE

C18H15F3N4O2S (408.0867766)


   

sym-Trimethyltriphenylcyclo trisiloxane

Cyclotrisiloxane, 2,4,6-trimethyl-2,4,6-triphenyl-

C21H24O3Si3 (408.10331940000003)


   

flavanthrone

flavanthrone

C28H12N2O2 (408.0898732)


   

2,6-dimethoxy-4-methyl-8-nitro-5-[3-(trifluoromethyl)phenoxy]quinoline

2,6-dimethoxy-4-methyl-8-nitro-5-[3-(trifluoromethyl)phenoxy]quinoline

C19H15F3N2O5 (408.0933016)


   

2-BENZAMIDO-3-(4-(N,N-BIS-(2-CHLOROETHYL)AMINO)PHENYL)PROPIONIC ACID

2-BENZAMIDO-3-(4-(N,N-BIS-(2-CHLOROETHYL)AMINO)PHENYL)PROPIONIC ACID

C20H22Cl2N2O3 (408.1007402)


   

1,4-Bis(7-chloroquinolin-4-yl)piperazine

1,4-Bis(7-chloroquinolin-4-yl)piperazine

C22H18Cl2N4 (408.09084479999996)


   

3,9-dibenzyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide

3,9-dibenzyl-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 3,9-dioxide

C19H22O6P2 (408.0891572)


   

Disperse Yellow 114

Disperse Yellow 114

C20H16N4O4S (408.08922160000003)


   

Contezolid

Contezolid

C18H15F3N4O4 (408.1045346)


D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C258 - Antibiotic

   

Leriglitazone hydrochloride

Leriglitazone hydrochloride

C19H21ClN2O4S (408.0910496000001)


C78272 - Agent Affecting Nervous System Leriglitazone (MIN-102; Hydroxypioglitazone) hydrochloride, a metabolite of pioglitazone. Leriglitazone hydrochloride PioOH is a PPARγ agonist, stabilizes the PPARγ activation function-2 (AF-2) co-activator binding surface and enhances co-activator binding, affording slightly better transcriptional efficacy. Leriglitazone hydrochloride binds to the PPARγ C-terminal ligand-binding domain (LBD) with a Ki of 1.2 μM，Leriglitazone induces transcriptional efficacy of the PPARγ (LBD) with an EC50 of 680 nM[1].

   

(1R)-N,6-Dihydroxy-7-methoxy-2-[(4-methoxyphenyl)sulfonyl]-1,2,3,4-tetrahydroisoquinoline-1-carboxamide

(1R)-N,6-Dihydroxy-7-methoxy-2-[(4-methoxyphenyl)sulfonyl]-1,2,3,4-tetrahydroisoquinoline-1-carboxamide

C18H20N2O7S (408.09911700000004)


   

N-[2-[[1-(4-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinyl]thio]-1-oxoethyl]-2-furancarbohydrazide

N-[2-[[1-(4-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinyl]thio]-1-oxoethyl]-2-furancarbohydrazide

C19H16N6O3S (408.10045460000003)


   

3-(4-chlorophenyl)-4-[(E)-(3,5-dimethyl-1-phenylpyrazol-4-yl)methylideneamino]-1H-1,2,4-triazole-5-thione

3-(4-chlorophenyl)-4-[(E)-(3,5-dimethyl-1-phenylpyrazol-4-yl)methylideneamino]-1H-1,2,4-triazole-5-thione

C20H17ClN6S (408.0923872)


   

4-[(2-chloro-6-fluorophenyl)-oxomethyl]-7-methyl-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one

4-[(2-chloro-6-fluorophenyl)-oxomethyl]-7-methyl-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one

C23H18ClFN2O2 (408.10407699999996)


   

2-(4-Bromophenyl)-2-oxoethyl 12-oxododec-9(Z)-enoate

2-(4-Bromophenyl)-2-oxoethyl 12-oxododec-9(Z)-enoate

C20H25BrO4 (408.093611)